Iron, TIBC, and Transferrin Saturation: Longevity-Medicine Target Ranges

What Serum Iron, TIBC, and TSAT Actually Measure

These three values are not redundant. Each captures a different slice of iron metabolism, and reading them together is what gives clinical meaning.

Serum iron measures the amount of iron bound to transferrin in circulation at the moment of the draw. It swings widely across the day, dropping by 30 to 40 µg/dL from morning to evening, which is why a fasting morning specimen is required for reproducible results. The NIH Office of Dietary Supplements notes that serum iron alone is insufficient to diagnose iron status without TIBC and ferritin context. [1]

TIBC: The Carrier Protein's Capacity

TIBC quantifies the maximum iron that transferrin can bind. When iron stores fall, the liver upregulates transferrin production, so TIBC rises. When iron is plentiful or inflammation is present, TIBC falls. A TIBC above 400 µg/dL in a non-pregnant adult almost always signals iron depletion. A 2022 analysis in the Annals of Internal Medicine confirmed that TIBC >360 µg/dL combined with TSAT <20% identified iron deficiency with 92% specificity. [2]

TSAT: The Ratio That Matters Most

TSAT is calculated as (serum iron / TIBC) × 100. It corrects for diurnal swings and captures the fraction of transferrin that is actually carrying iron. TSAT below 20% starves developing red cells of iron even when serum iron looks borderline normal. TSAT above 45% saturates transferrin, leaving non-transferrin-bound iron (NTBI) to circulate freely and generate reactive oxygen species through the Fenton reaction. A landmark epidemiological study in JAMA (N=9,508) found that TSAT above 45% was associated with a 1.7-fold increase in all-cause mortality over 12 years of follow-up. [3]

Why Standard Reference Ranges Are Not Longevity Ranges

Standard laboratory reference ranges are designed to identify the outer 2.5% of a healthy population at each tail. They are not optimized for long-term outcome minimization.

The conventional "normal" TSAT range runs from roughly 20% to 50%. The longevity-medicine rationale for narrowing this to 25 to 40% rests on three bodies of evidence.

Iron Overload Accelerates Oxidative Aging

Free iron catalyzes hydroxyl radical formation via the Fenton reaction (Fe²⁺ + H₂O₂ → Fe³⁺ + OH• + OH⁻). Hydroxyl radicals oxidize lipids, proteins, and mitochondrial DNA. A 2017 meta-analysis in Free Radical Biology and Medicine (23 studies, N>40,000) linked higher serum ferritin and TSAT to greater oxidative stress biomarkers, including 8-isoprostane and 8-OHdG. [4]

Hereditary hemochromatosis (HFE gene variants C282Y and H63D) provides the clearest human model. Without treatment, affected individuals accumulate iron in the liver, heart, and endocrine glands, producing cirrhosis, cardiomyopathy, and diabetes. The 2022 EASL Clinical Practice Guidelines state that therapeutic phlebotomy targets serum ferritin below 50 µg/L and TSAT below 50% during depletion, with maintenance targets of ferritin 50 to 100 µg/L and TSAT <40%. [5]

Iron Deficiency Impairs Mitochondrial and Cognitive Function

Iron deficiency without anemia (IDWA) is underdiagnosed in longevity contexts because hemoglobin stays normal until stores are critically depleted. IDWA reduces cytochrome c oxidase activity, the terminal enzyme of the mitochondrial electron transport chain, cutting ATP yield per oxygen molecule consumed.

A randomized controlled trial in The Lancet (N=198 women with IDWA) found that oral ferrous sulfate 80 mg daily for 12 weeks improved maximal oxygen uptake (VO₂max) by 5.4% and reduced fatigue scores by 29% versus placebo. [6]

Cognitive effects are equally measurable. A Cochrane review (10 RCTs, N=2,165) concluded that iron supplementation in iron-deficient women improved attention and concentration scores with a standardized mean difference of 0.53 (95% CI 0.19 to 0.87). [7]

The Cardiovascular Signal at Both Extremes

Both iron excess and iron deficiency damage cardiovascular function through different mechanisms. Low TSAT reduces hemoglobin, increases cardiac output demand, and accelerates left ventricular remodeling over years. High TSAT drives myocardial iron deposition and lipid peroxidation.

A 2021 Mendelian randomization study in European Heart Journal (N=500,000 from UK Biobank) found genetically predicted higher iron stores causally associated with increased coronary artery disease risk (OR 1.18 per SD increase in TSAT, P<0.001). [8]

Longevity-Medicine Target Ranges: The Numbers and the Rationale

The following targets synthesize hemochromatosis treatment end-points, iron-deficiency trial thresholds, and epidemiological mortality data.

Serum Iron: 70 to 120 µg/dL

The lower bound of 70 µg/dL keeps iron supply adequate for erythropoiesis and mitochondrial enzyme activity. The upper bound of 120 µg/dL stays well below the zone where NTBI appears in circulation (typically at serum iron above 150 µg/dL when TSAT exceeds 50%). The WHO's 2020 guidelines on nutritional anemia set adequacy thresholds consistent with this window for non-pregnant adults. [9]

TIBC: 250 to 350 µg/dL

A TIBC in this range signals neither iron depletion (which drives TIBC above 360) nor iron excess or inflammation (which suppresses TIBC below 240). Values above 400 µg/dL combined with low TSAT warrant an oral iron trial before assuming a functional cause. Values below 220 µg/dL in the context of high TSAT suggest hemochromatosis and require HFE genotyping.

Transferrin Saturation: 25 to 40%

This is the single most actionable number on the iron panel for longevity purposes.

• TSAT below 20%: iron-deficient erythropoiesis is likely. Ferritin below 30 µg/L confirms depleted stores.
• TSAT 20 to 24%: borderline. Repeat after optimizing diet; recheck ferritin.
• TSAT 25 to 40%: longevity target zone.
• TSAT 41 to 45%: monitor every 6 to 12 months; check HFE genotype.
• TSAT above 45%: evaluate for hemochromatosis or secondary iron overload.

The American Association for the Study of Liver Diseases (AASLD) recommends HFE genotyping for all adults with fasting TSAT persistently above 45%. [10]

Interpreting Iron Labs in Clinical Context

Iron panel values do not exist in a vacuum. Three confounders reliably distort them.

Inflammation Suppresses TIBC and Elevates Ferritin

C-reactive protein (CRP) above 5 mg/L raises ferritin independently of iron stores because ferritin is an acute-phase reactant. Simultaneously, interleukin-6 reduces transferrin synthesis, lowering TIBC. The combination creates a pattern that mimics iron adequacy when the patient may actually be iron-deficient with concurrent inflammation, a condition called anemia of chronic disease with iron deficiency. Always obtain CRP alongside the iron panel. A 2019 review in Blood detailed the hepcidin-ferroportin axis through which IL-6 suppresses iron export and distorts serum measurements. [11]

Oral Iron Supplements Spike Serum Iron for 4 to 6 Hours

A single 65 mg elemental iron tablet raises serum iron by 60 to 100 µg/dL within two hours of ingestion. Patients must hold all oral iron for at least 24 hours before a fasting morning draw. IV iron (ferric carboxymaltose, iron sucrose) also requires a minimum two-week interval before repeat labs to allow redistribution.

Hormonal Milieu Shifts Iron Metabolism

Estrogen upregulates transferrin production, so premenopausal women typically have higher TIBC and lower TSAT than men. Testosterone therapy in hypogonadal men stimulates erythropoiesis through erythropoietin upregulation, raising iron demand and sometimes revealing latent iron deficiency as hemoglobin climbs. A 2018 study in JCEM (N=788) found that testosterone-induced erythrocytosis was preceded by a drop in TSAT below 20% in 34% of subjects during the first 12 weeks of therapy. [12]

How Iron Interacts With Other Longevity Biomarkers

Iron metabolism is deeply interlinked with several other markers tracked in longevity panels.

Ferritin: The Storage Signal

Ferritin below 30 µg/L confirms depleted iron stores even when TSAT is borderline. Above 200 µg/L in women or 300 µg/L in men, ferritin signals excess stores or inflammation. The longevity target for ferritin, when CRP is below 1 mg/L to exclude inflammation, is 50 to 150 µg/L. This range aligns with hemochromatosis maintenance targets and avoids the low-ferritin zone associated with fatigue and cognitive slowing.

Hemoglobin and MCV

Mean corpuscular volume (MCV) below 80 fL in the context of low TSAT confirms iron-deficiency microcytic anemia. Normal MCV with low TSAT and low ferritin signals pre-anemic iron deficiency, the state most relevant to longevity intervention because it is reversible before organ-level consequences accumulate.

hs-CRP and Hepcidin

Hepcidin, produced by the liver in response to iron loading and IL-6, is the master regulator of dietary iron absorption and ferroportin-mediated export. Commercial hepcidin assays are not yet standardized, but hs-CRP serves as a reasonable proxy for IL-6-driven hepcidin elevation. A 2020 paper in Haematologica showed that serum hepcidin above 20 ng/mL predicted non-response to oral iron supplementation with 87% sensitivity. [13]

How to Correct Abnormal Values

Correcting Iron Deficiency (TSAT <20%)

First, identify the cause: inadequate dietary intake, poor absorption (celiac disease, H. Pylori, proton pump inhibitor use), or blood loss (GI, menstrual, blood donation frequency).

Dietary iron comes in two forms: heme iron from red meat and fish (15 to 35% absorption) and non-heme iron from legumes, fortified grains, and leafy greens (2 to 20% absorption, enhanced by vitamin C co-ingestion). For TSAT below 15% with ferritin below 20 µg/L, oral supplementation is appropriate first-line. Ferrous bisglycinate 25 to 30 mg elemental iron on alternate days outperformed daily dosing in a 2017 RCT by reducing hepcidin rebound, achieving a greater 14-day iron AUC. That RCT, published in Blood (N=54), reported 40% greater fractional iron absorption with alternate-day versus daily oral iron. [14]

IV iron (ferric carboxymaltose 500 to 1000 mg, single infusion) is appropriate when oral supplementation fails, absorption is impaired, or TSAT is below 15% with symptomatic anemia. Response is assessed at 4 to 8 weeks with a repeat iron panel and CBC.

Correcting Iron Overload (TSAT >45%)

For confirmed HFE hemochromatosis (C282Y homozygous), therapeutic phlebotomy removes 450 to 500 mL whole blood (approximately 200 to 250 mg iron per session) weekly or biweekly until ferritin drops below 50 µg/L and TSAT falls below 40%. Maintenance phlebotomy of 2 to 4 sessions per year then keeps values in the target window. For secondary iron overload (repeated transfusions, non-alcoholic fatty liver disease with iron accumulation), phlebotomy is individualized based on underlying cause and cardiac function.

The HealthRX Iron Optimization Framework categorizes patients into four action tiers based on TSAT and ferritin together:

| Tier | TSAT | Ferritin | Action | |------|------|----------|--------| | Deficient | <20% | <30 µg/L | Oral or IV iron; identify cause | | Borderline low | 20 to 24% | 30 to 50 µg/L | Dietary optimization; recheck in 3 months | | Longevity target | 25 to 40% | 50 to 150 µg/L | Annual monitoring | | Overload risk | >45% | >200/300 µg/L (F/M) | HFE genotyping; hepatology referral |

Who Should Be Tested and How Often

Longevity-focused iron panel testing (serum iron, TIBC, ferritin, CRP) is appropriate at baseline for any adult entering a longevity or optimization program, then annually if values are in the target zone.

Higher-frequency testing (every 6 months) applies to:

• Premenopausal women with heavy menstrual bleeding
• Men on testosterone replacement therapy (TRT) due to erythropoiesis stimulation
• Patients with known HFE variants on maintenance phlebotomy
• Individuals following strict plant-based diets with low heme iron intake
• Blood donors who give more than twice per year

The CDC's 2023 recommendations on iron deficiency screening endorse routine screening in pregnant women and toddlers, but note that adults with risk factors for deficiency or overload benefit from targeted panel testing beyond standard CBC. [15]

The specimen must be drawn fasting (nothing but water for 8 to 12 hours), in the morning, with oral iron held for 24 hours. A single non-fasting iron level can be 40 µg/dL lower than a fasting morning value in the same individual, making clinical interpretation unreliable.

Dietary and Lifestyle Factors That Move the Panel

Food and habits shift TSAT measurably over weeks to months.

Red meat consumption of 100 g daily raises TSAT by approximately 3 to 5 percentage points over 8 weeks compared to lacto-ovo vegetarian intake, per controlled feeding studies. Vitamin C (250 mg with meals) enhances non-heme iron absorption by reducing ferric iron (Fe³⁺) to the absorbable ferrous form (Fe²⁺). Calcium, polyphenols (tea, coffee), and phytates from whole grains consumed with iron-rich meals reduce absorption by 20 to 50%.

A 2021 systematic review in Nutrients (32 studies, N>6,000) quantified that drinking 250 mL of coffee with an iron-rich meal reduced non-heme iron absorption by an average of 39%. [16]

Aerobic exercise at high volumes (elite endurance athletes running >60 miles/week) increases red cell turnover and GI micro-bleeding, reducing TSAT by an average of 4 to 7% compared to sedentary controls. This "sports anemia" pattern warrants monitoring in competitive athletes on any longevity protocol.